⌘K

Home/Filings/4/0001615219-20-000003

4//SEC Filing

Jordan Scott 4

Accession 0001615219-20-000003

CIK 0001615219other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:48 PM ET

Size

4.7 KB

Accession

0001615219-20-000003

Insider Transaction Report

Form 4

Period: 2020-02-18

Salarius Pharmaceuticals, Inc.SLRX

Chief Financial Officer

Transactions

Purchase
Common Stock
2020-02-18$0.90/sh+11,300$10,170→ 31,609 total

Footnotes (1)

[F1]Includes 2,538 shares of unvested Common Stock which will become fully vested on June 30, 2020.

Documents

1 file

4
wf-form4_158206246390469.xmlPrimary
FORM 4

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1

filerCIK 0001769747

Filing Metadata

Form type: 4
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 4:48 PM ET
Size: 4.7 KB

View on SEC.gov